Common questions about Durolane (FAQ)
Q: What is the main difference between Durolane and other hyaluronic acid injections?
According to official product information, Durolane is distinguished by its use of highly stabilized, cross-linked sodium hyaluronate. This composition is described in the product labeling as contributing to the longevity of the substance within the joint. Clinical studies have indicated that this single-injection treatment course is comparable to the effectiveness achieved with some hyaluronic acid products that require multiple injections.
Q: How long does Durolane typically stay in the knee joint?
Information from clinical data indicates that the product remains in the joint for an extended period. The reported half-life of the product within the joint cavity is approximately 30 days or four weeks.
Q: Is Durolane available without a prescription in some countries?
Regulatory bodies classify Durolane as a prescription medical device. This means it is restricted to sale by or on the order of a licensed healthcare practitioner. It is therefore not available as an over-the-counter (OTC) product.
Q: Is there a limit to how many times a joint can be treated with Durolane?
Official regulatory documents state that the safety and effectiveness of repeated cycles of Durolane treatment have not been established in clinical studies. The standard procedure specifies that a subsequent treatment should be administered no sooner than 6 months after the initial injection.
Q: Does Durolane interact with common supplements like glucosamine or chondroitin?
Official labeling focuses on a single local incompatibility involving specific disinfectants at the injection site. For systemic substances like oral supplements, no documented systemic interactions are noted in regulatory sources for this locally acting product.
Q: What are the typical ingredients listed on the Durolane label?
The product is a viscous gel that contains the single active ingredient, sodium hyaluronate. The sodium hyaluronate is suspended in phosphate-buffered saline, which serves as the primary inactive component of the gel.
Q: Why are people with known joint infections excluded from using Durolane?
The use of Durolane is strictly prohibited (contraindicated) if a patient has an infection in the joint or a skin infection at the intended injection site. This is a mandatory safety constraint intended to avoid the risk of serious adverse events, such as a severe joint infection (septic arthritis).
Q: How quickly can a person expect to notice something after getting the injection?
Clinical studies generally evaluate the full effect of the product at longer time points, such as 12 or 26 weeks. However, initial assessments of safety and efficacy were sometimes recorded in early patient visits, such as those occurring around 2 weeks after the injection.
Q: Are there specific activities I should avoid immediately following the procedure?
Official documents advise that specific restrictions on activity apply for the first 48 hours following the procedure. During this time, strenuous activities, such as jogging or heavy lifting, and prolonged weight-bearing activities (like standing for more than an hour) are advised to be avoided.
Q: Why do doctors recommend resting the joint after the Durolane injection?
The advice to avoid heavy activity for 48 hours is a post-injection instruction noted in the official regulatory documents. This temporary restriction is intended to allow the injected joint to recover immediately following the procedure.
Q: How does Durolane compare to physical therapy alone?
Official indications state that Durolane is for adult patients with osteoarthritis knee pain who have not responded adequately to conservative non-pharmacological therapies. This patient population includes those who did not experience sufficient relief from interventions such as physical therapy or simple pain relievers alone.
Q: What happens if I accidentally put too much pressure on the joint after the injection?
Regulatory documents advise against strenuous activity or putting excessive pressure on the joint for 48 hours after the injection. Failure to follow this instruction may be associated with an increase in transient local adverse reactions, such as temporary pain, swelling, or fluid buildup in the joint.
Q: Does Durolane contain preservatives?
Official information states that the product is a sterile, single-use gel that must be used immediately after the sealed package is opened. These conditions are consistent with a formulation that does not contain multi-dose preservatives.
Q: Can I drive immediately after having a Durolane injection?
Regulatory documents do not contain a specific prohibition on driving. However, because common adverse reactions include transient pain and stiffness at the injection site, these symptoms may affect activities that require full and comfortable joint mobility.
Q: How long after the treatment can a person usually return to intense exercise?
The required restriction period for intense activity is mandated for the first 48 hours following the injection. Patients are advised by regulatory documents to avoid strenuous or prolonged weight-bearing activities during this time.
